Manu Jain
Distinguished in Secondary Immunodeficiency (SID)

Dr. Manu Jain

Pulmonary Medicine
Northwestern Medical Group
676 N St Clair St Ste 1520, Arkes Pavilion, 
Chicago, IL 
Offers Telehealth
37 Years of Experience
Distinguished in Secondary Immunodeficiency (SID)
Northwestern Medical Group
676 N St Clair St Ste 1520, Arkes Pavilion, 
Chicago, IL 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Manu Jain is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Jain has been practicing medicine for over 37 years and is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Cystic Fibrosis, Secondary Immunodeficiency (SID), Newborn Jaundice, Bronchiectasis, and Gastrostomy.

His clinical research consists of co-authoring 138 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Chicago Pritzker School Of Medicine, 1989.0
Residency
University of Chicago
Specialties
Pulmonary Medicine
Licenses
Internal Medicine in IL
Board Certifications
American Board Of Internal Medicine - Critical Care Medicine (Certified)
Fellowships
University of Chicago
Hospital Affiliations
Northwestern Memorial Hospital
Northwestern Lake Forest Hospital
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Alliance
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Northern Plains Alliance
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE PDP
TeamCare
  • OTHER COMMERCIAL
Trustmark
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

676 N St Clair St Ste 1520, Arkes Pavilion, Chicago, IL 60611
Call: 312-695-1800

Additional Areas of Focus

Dr. Jain has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Bronchiectasis

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Prospective Evaluation of a Standardized Approach to Diagnosis (PREDICT) and Treatment (PATIENCE) of Nontuberculous Mycobacteria Disease in Cystic Fibrosis
Enrollment Status: Enrolling_by_invitation
Publish Date: April 02, 2024
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
A Phase 1b/2a, Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Single and Multiple Ascending Dose Study to Evaluate the Safety and Tolerability of AP-PA02 Multi-Phage Therapeutic Candidate for Inhalation in Subjects With Cystic Fibrosis and Chronic Pulmonary Pseudomonas Aeruginosa (Pa) Infection
Enrollment Status: Completed
Publish Date: January 31, 2024
Intervention Type: Other, Biological
Study Drug: AP-PA02 Bacteriophage
Study Phase: Phase 1/Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
Enrollment Status: Completed
Publish Date: January 18, 2023
Intervention Type: Drug, Other
Study Drug: Lenabasum
Study Phase: Phase 2
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Grant Number: R34HL122558
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis Grant Number: R34HL122558
Enrollment Status: Completed
Publish Date: August 25, 2021
Intervention Type: Drug
Study Drugs: Bortezomib, Mycophenolate mofetil
Study Phase: Phase 2
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
TEACH Trial: Testing the Effect of Adding CHronic Azithromycin to Inhaled Tobramycin. A Randomized, Placebo-controlled, Double-blinded Trial of Azithromycin 500mg Thrice Weekly in Combination With Inhaled Tobramycin
Enrollment Status: Completed
Publish Date: June 28, 2021
Intervention Type: Drug
Study Phase: Phase 4
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Phase 1b, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacokinetics of QR-010 in Subjects With Homozygous ΔF508 Cystic Fibrosis
Enrollment Status: Completed
Publish Date: February 06, 2019
Intervention Type: Drug
Study Phase: Phase 1/Phase 2
View 6 Less Clinical Trials

138 Total Publications

Cross-Modal Imaging in Noninvasive Identification of Histologic Features of Skin.
Cross-Modal Imaging in Noninvasive Identification of Histologic Features of Skin.
Journal: JAMA dermatology
Published: November 05, 2025
View All 138 Publications
Similar Doctors
Advanced in Secondary Immunodeficiency (SID)
Dr. Michelle L. Prickett
Pulmonary Medicine
Advanced in Secondary Immunodeficiency (SID)
Dr. Michelle L. Prickett
Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-695-1800
Experience:
22+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Michelle Prickett is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Prickett has been practicing medicine for over 22 years and is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). Her top areas of expertise are Cystic Fibrosis, Bronchiectasis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Gastrostomy.

Bradford C. Bemiss
Advanced in Secondary Immunodeficiency (SID)
Dr. Bradford C. Bemiss
Pulmonary Medicine
Advanced in Secondary Immunodeficiency (SID)
Dr. Bradford C. Bemiss
Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-695-1800
Experience:
18+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Bradford Bemiss is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Bemiss has been practicing medicine for over 18 years and is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Acute Interstitial Pneumonia, Hypersensitivity Pneumonitis, Interstitial Lung Disease, Lung Transplant, and Gastrostomy.

Marc A. Sala
Advanced in Secondary Immunodeficiency (SID)
Dr. Marc A. Sala
Pulmonary Medicine
Advanced in Secondary Immunodeficiency (SID)
Dr. Marc A. Sala
Pulmonary Medicine
676 N St Clair St Ste 2100, Arkes Pavilion, 
Chicago, IL 
 (0.1 miles away)
312-695-1800
Experience:
17+ years
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Marc Sala is a Pulmonary Medicine provider in Chicago, Illinois. Dr. Sala has been practicing medicine for over 17 years and is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). His top areas of expertise are Cystic Fibrosis, Bronchiectasis, Secondary Immunodeficiency (SID), Newborn Jaundice, and Gastrostomy.

VIEW MORE SECONDARY IMMUNODEFICIENCY (SID) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Jain's expertise for a condition
ConditionClose
  • Elite
  • Cystic Fibrosis
    Dr. Jain is
    Elite
    . Learn about Cystic Fibrosis.
    See more Cystic Fibrosis experts
  • Distinguished
  • Newborn Jaundice
    Dr. Jain is
    Distinguished
    . Learn about Newborn Jaundice.
    See more Newborn Jaundice experts
  • Secondary Immunodeficiency (SID)
    Dr. Jain is
    Distinguished
    . Learn about Secondary Immunodeficiency (SID).
    See more Secondary Immunodeficiency (SID) experts
  • Advanced
  • Bronchiectasis
    Dr. Jain is
    Advanced
    . Learn about Bronchiectasis.
    See more Bronchiectasis experts
  • Pseudomonas Stutzeri Infections
    Dr. Jain is
    Advanced
    . Learn about Pseudomonas Stutzeri Infections.
    See more Pseudomonas Stutzeri Infections experts
  • Pulmonary Fibrosis
    Dr. Jain is
    Advanced
    . Learn about Pulmonary Fibrosis.
    See more Pulmonary Fibrosis experts
  • Experienced
  • Acute Interstitial Pneumonia
    Dr. Jain is
    Experienced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Acute Respiratory Distress Syndrome (ARDS)
    Dr. Jain is
    Experienced
    . Learn about Acute Respiratory Distress Syndrome (ARDS).
    See more Acute Respiratory Distress Syndrome (ARDS) experts
  • Bronchiolitis Obliterans
    Dr. Jain is
    Experienced
    . Learn about Bronchiolitis Obliterans.
    See more Bronchiolitis Obliterans experts
  • COVID-19
    Dr. Jain is
    Experienced
    . Learn about COVID-19.
    See more COVID-19 experts
  • Gastrostomy
    Dr. Jain is
    Experienced
    . Learn about Gastrostomy.
    See more Gastrostomy experts
  • Hypersensitivity Pneumonitis
    Dr. Jain is
    Experienced
    . Learn about Hypersensitivity Pneumonitis.
    See more Hypersensitivity Pneumonitis experts
View All 13 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.